TOP GUIDELINES OF MBL77

Not all sufferers with CLL involve therapy. Even with all recent advancements, the iwCLL however endorses watchful observation for patients with asymptomatic sickness.86 This advice is predicated on at least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104